25 Feb Modern HIV prevention for Women
Cate Hankins, member of the organizing committee for the HIV and Women Workshop held in Boston on February 20-21, chaired an exciting session on biomedical HIV prevention for women, contraception and HIV, and multipurpose technologies for women. “What’s next for women?” was the question on the minds of many, after results were released from two trials that looked at one of the most promising new HIV prevention tools of our time: the long-acting dapivirine vaginal ring, a female-controlled HIV prevention method that could potentially protect women for up to a month at a time. ASPIRE (MTN 020) and The Ring Study (IPM 027) looked at the safety and effectiveness of these women-controlled devices; their results were among the most anticipated data to be released at the conference.